| 000 | 01777 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250517101915.0 | ||
| 264 | 0 | _c20170814 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2016.137 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStorti, P | |
| 245 | 0 | 0 |
_aGalectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo. _h[electronic resource] |
| 260 |
_bLeukemia _c12 2016 |
||
| 300 |
_a2351-2363 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Hypoxia |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aGalectin 1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMultiple Myeloma _xblood supply |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aMarchica, V | |
| 700 | 1 | _aAiroldi, I | |
| 700 | 1 | _aDonofrio, G | |
| 700 | 1 | _aFiorini, E | |
| 700 | 1 | _aFerri, V | |
| 700 | 1 | _aGuasco, D | |
| 700 | 1 | _aTodoerti, K | |
| 700 | 1 | _aSilbermann, R | |
| 700 | 1 | _aAnderson, J L | |
| 700 | 1 | _aZhao, W | |
| 700 | 1 | _aAgnelli, L | |
| 700 | 1 | _aBolzoni, M | |
| 700 | 1 | _aMartella, E | |
| 700 | 1 | _aMancini, C | |
| 700 | 1 | _aCampanini, N | |
| 700 | 1 | _aNoonan, D M | |
| 700 | 1 | _aPetronini, P G | |
| 700 | 1 | _aNeri, A | |
| 700 | 1 | _aAversa, F | |
| 700 | 1 | _aRoodman, G D | |
| 700 | 1 | _aGiuliani, N | |
| 773 | 0 |
_tLeukemia _gvol. 30 _gno. 12 _gp. 2351-2363 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2016.137 _zAvailable from publisher's website |
| 999 |
_c26132283 _d26132283 |
||